1.Chlamydia.
Korean Journal of Clinical Microbiology 2000;3(1):1-4
No abstract available.
Chlamydia*
2.Immunotyping of chlamydia trachomatis by monoclonal antibodies.
Kyoo Suk YOON ; Duk Uhn KIM ; Tae Yul CHOI
Korean Journal of Infectious Diseases 1993;25(1):19-26
No abstract available.
Antibodies, Monoclonal*
;
Chlamydia trachomatis*
;
Chlamydia*
3.Clinical study for the chlamydia trachomatis infection in the cervix .
Hee Soo CHUNG ; Kyoung Soon SHIN ; Kyoung Suk PARK ; Jung Ja AHN ; Bock Hi WOO
Korean Journal of Obstetrics and Gynecology 1992;35(8):1190-1201
No abstract available.
Cervix Uteri*
;
Chlamydia trachomatis*
;
Chlamydia*
;
Female
4.Clinical Investigation of Chlamydia Pneumonia in Infants.
Jong Hoon PARK ; Se Geon PARK ; Kwang Chul LEE ; Young Sook HONG ; Young Chang VTOCKGO
Journal of the Korean Pediatric Society 1990;33(8):1065-1073
No abstract available.
Chlamydia*
;
Humans
;
Infant*
;
Pneumonia*
5.Chlamydia pneumoniae and Atherosclerosis.
Korean Journal of Clinical Microbiology 2001;4(2):78-81
No abstract available.
Atherosclerosis*
;
Chlamydia*
;
Chlamydophila pneumoniae*
6.Prevalence of chlamydia infections in men and women with urethral and vaginal discharge syndromes at the Institute of Dermato-Venereology, Hanoi 2001
Journal of Preventive Medicine 2004;14(1):58-62
In 2001, 300 patients with urethral, vaginal discharge syndromes were tested at National Institute of Dermato-Venereology and detected 27 patients infected Chlamydia trachomatis (9%). Prevalence of Chlamydia infection was 11.49% among men and 5.55% among women. The most Chlamydia trachomatis-induced genital infections were people aged 21-40 (9%)
Chlamydia
;
epidemiology
;
men
;
women
7.Glycogen Granules within the Co-cultured Conjunctival Epithelial Cells of Rabbit with Chlamydia Trachomatis.
BoklKwan JUN ; Myung Kyoo KO ; Dong Seob KIM
Journal of the Korean Ophthalmological Society 1999;40(2):312-317
Inclusion bodies containing glycogen granules are characteristic feature of infected cells with Chlamydia trachomatis(C. trachomatis). In this study, we investigated the serial changes of the glycogen granules in a rabbit conjunctival epithelial cells co-cultivated with C. trachomatis.The epithelial cells isolated grom conjunctiva of rabbit were initially cultured for 3 weeks. After the cells had attained confluency, they were infected with C. trachomatis serotype D. After co-cultivation for 24, 48 and 96 hours, electronmicroscopic study was performed.After co-cultivation for 24 hours, a few glycogen granules were observed within the premature inclusion body containing some elementary bodies and reticulate bodies. After 48 hours of co-cultivation, typical inclusion bodies were observed and numerous electron-dense glycogen granules predominated around reticulate bodies. After 96 hours of co-cultivation, scattered glycogen granules were observed in granular pattern within the expanding inclusion occupying the bulk of the host cell cytoplasm.These results suggest that glycogen granules are closely related to the developmental cycle of the C. trachomatis and they may be an energy source for active multiplication of the reticulate bodies.
Chlamydia trachomatis*
;
Chlamydia*
;
Conjunctiva
;
Epithelial Cells*
;
Glycogen*
;
Inclusion Bodies
8.Detection of Chlamydia Trachomatis in Non-gonococcal Urethritis and Chronic Prostatitis by Enzyme Immunoassay Technique.
Dea Yeung CHUNG ; Se Kyong KIM
Korean Journal of Urology 1987;28(5):639-643
Possible role of chlamydia trachomatis (C. trachomatis) in non-gonococcal Urethritis and chronic prostatitis was investigated by enzyme immunoassay technique in a study of 85 cases of non-gonococcal urethritis and 23 chronic prostatitis cases. 1. C. trachomatis was detected from 21 (24.7%) of 85 non-gonococcal urethritis patients and third decade represented the highest positive rate. 2. C. trachomatis was detected from 5 cases (21.7%) of 23 chronic prostatitis patients. 3. A significantly higher positive C. trachomatis detection rate of 60. 7% was obtained from those with a profuse urethral discharge compared with those with a scanty discharge. 4. A significantly higher positive C. trachomatis detection rate of 52.3% was obtained from cases with no previous history of urethritis compared with those who had previous history of urethritis in 85 cases of non-gonococcal urethritis.
Chlamydia trachomatis*
;
Chlamydia*
;
Humans
;
Immunoenzyme Techniques*
;
Prostatitis*
;
Urethritis*
9.Comparison of Chlamydia Trachomatis Antigen Detection Rate between Endourethral Swab and Urine Examination.
Suk Chun HONG ; Heung Jae PARK ; Chil Kun KWON
Korean Journal of Urology 1995;36(11):1220-1224
Chlamydia trachomatis is known as a major causative microorganism in non-gonococcal urethritis(NGU) in men. We examined two kinds of specimens simultaneously, endourethral swab and urine, in each patient to determine the reliability of these two different specimens for the detection of the Chlamydia trachomatis antigen in male NGU patients using ELISA method. Tota1 273 patients entered this study were divided into two groups according to sampling order of urine and endourethral swab. In group A(141 patients), we took endourethral swab first, then first portion of voided urine was caught. In group B(132 patients), endourethral swab was performed after urine sampling. Twenty five out of 273 patients(9.2%) showed Chlamydia trachomatis antigen positive in endourethral swab sample and 1 out of 273 patients(0.4%) was positive in urine sample. There was no significant difference of antigen positive rate of endourethral swab examination between group A and group B. Our data suggest that examination of endourethral swab is more reliable method for the detection of the Chlamydia trachomatis antigen than urine examination in male NGU patient.
Chlamydia trachomatis*
;
Chlamydia*
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Male
10.Antimicrobial activity of erythromycin, doxycycline, pipemidic acid, and enoxacine against chlamydia trachomatis.
Tea Yeal CHOI ; Young Nam WOO ; Dong Han KIM
Korean Journal of Infectious Diseases 1992;24(2):99-105
No abstract available.
Chlamydia trachomatis*
;
Chlamydia*
;
Doxycycline*
;
Enoxacin*
;
Erythromycin*
;
Pipemidic Acid*